Inactivating mutations block the tumor necrosis factor-alpha-converting enzyme in the early secretory pathway

Teresa Villanueva de la Torre1, Joan J Bech-Serra, Soraya Ruiz-Paz

  • 1Laboratori de Recerca Oncològica, Servei d'Oncologia Mèdica, Hospital Universitari Vall d'Hebron, Psg. Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Insights

Mutations in proTNF-alpha converting enzyme (TACE) prevent its proper processing and cell surface transport. Introducing wild-type TACE rescues the shedding defect in mutant cells, highlighting TACE biosynthesis importance.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Background:

  • The shedding of transmembrane protein ectodomains is a critical biological process.
  • Pro-transforming growth factor-alpha (proTGF-alpha) and amyloid-beta precursor protein (APP) shedding are mediated by proTNF-alpha converting enzyme (TACE).
  • Mutant cell lines M1 and M2 exhibit defects in proTGF-alpha and APP shedding due to inactive TACE accumulation in the early secretory pathway.

Purpose of the Study:

  • To investigate the role of TACE mutations in the observed shedding defects in M1 and M2 cells.
  • To determine if wild-type TACE can rescue the shedding phenotype in mutant cells.
  • To elucidate the importance of early biosynthesis steps in TACE function.

Main Methods:

  • Stable transfection of wild-type TACE into M2 mutant cells.
  • Assessment of TACE processing and cell surface transport.
  • Evaluation of proTGF-alpha and APP shedding rescue in transfected cells.
  • Analysis of TACE in M1 cells and rescue via wild-type TACE transfection.

Main Results:

  • Wild-type TACE, when transfected into M2 cells, was correctly processed, transported to the cell surface, and restored proTGF-alpha and APP shedding.
  • M1 cells were also found to express mutant TACE, and transfection with wild-type TACE rescued the shedding defect.
  • These findings indicate that inactivating mutations in TACE lead to its accumulation in the early secretory pathway.

Conclusions:

  • The study confirms that mutations in TACE are responsible for the shedding defects observed in M1 and M2 cells.
  • Successful rescue by wild-type TACE highlights the critical role of proper TACE biosynthesis and trafficking.
  • The results underscore the significance of the initial stages of TACE biosynthesis for its enzymatic activity and function.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...